By fusing EpCAM-specific DARPins to the AAV2 capsid, researchers have successfully developed tumor-targeted AAV vectors, such as EpCAM-AAV [14] and PTS-coupled AAV [15]. This evidence concerns the gene EPCAM and neoplasm.